Mississippi mud in the 1990s: Risks and outcomes of vancomycin- associated toxicity in general oncology practice

Cancer

Volumn 83, Issue 12, 1998, Pages 2597-2607

  Elting, L S ^a   Rubenstein, E B ^a   Kurtin, D ^a   Rolston, K V I ^a   Fangtang, J ^a   Martin, C G ^a   Raad, I I ^a   Whimbey, E E ^a   Manzullo, E ^a   Bodey, G P ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Clinical prediction rules; Nephrotoxicity; Vancomycin; Vancomycin associated toxicity

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CANCER PATIENT; DRUG INDUCED DISEASE; FEMALE; GENERAL PRACTICE; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; ONCOLOGY; OTOTOXICITY; PHLEBITIS; PRIORITY JOURNAL; RASH; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG RESISTANCE, MICROBIAL; FEMALE; HEARING DISORDERS; HUMANS; IMMUNOCOMPROMISED HOST; KIDNEY; MALE; MIDDLE AGED; NEOPLASMS; PHLEBITIS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; VANCOMYCIN;

EID: 0032535457     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19981215)83:12<2597::AID-CNCR27>3.0.CO;2-L     Document Type: Article

References (37)